Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT Plus for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Stephen Hahn

Pharmalot By Ed Silverman

Pressure mounts on FDA chief to stick with science for Covid-19 vaccine approvals

"They talk about Operation Warp Speed, but [emergency use authorization] would simply be warped," said Public Citizen's Sidney Wolfe.

pills

Pharmalot By Ed Silverman

Italy becomes first country to require pharma to disclose public funding for R&D costs

Remdesivir vial in bag

Pharma By Ed Silverman

State attorneys general urge HHS to sidestep Gilead patents to increase remdesivir access

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca strikes first Covid-19 deal with a Chinese company; vaccine trials face distrust from minority groups

Gilead office remdesivir

Pharmalot By Ed Silverman

Gilead faces renewed pressure to pursue remdesivir-like compound to fight Covid-19

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: Regeneron Covid-19 antibody treatment works in animals; Warren asks SEC to probe Kodak trading

Pills price rebate

Pharmalot By Ed Silverman

Prescription drugs may be more affordable than you think — unless you pay cash

advertisement

Zantac

Pharmalot By Ed Silverman

Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills

Pharmalot By Ed Silverman

Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine

Generic pills on red background

Pharmalot By Ed Silverman

Music in drug ads makes it easier for the public to tune out side effects, advocates argue

FDA through the window

Pharmalot By Ed Silverman

In a blow to Catalyst, judge recommends tossing its lawsuit against FDA

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns

Sanofi

Pharma By Matthew Herper

Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses

Pharmalot By Ed Silverman

Pharmalittle: Drug makers build Covid-19 vaccine supply chains; VCs are still spending on biotechs

Cash on yellow background

Pharmalot By Ed Silverman

Drug maker settles charges of offering ‘bogus’ research grants to boost use of its medicine

money shower

Pharma By Kate Sheridan

Venture capitalists are still showering biotechs with cash, even as the coronavirus upends markets

Various medications

Pharmalot By Ed Silverman

Seeking to battle high drug prices and the opioid crisis, two states ponder banning gifts to doctors

Pharmalot By Ed Silverman

Pharmalittle: Global supply chain not ready for Covid-19 vaccines; Moderna may price its vaccine at up to $60

23andMe 5/12

Pharma By Matthew Herper

Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

Virginia Coronavirus Testing

Pharmalot By Ed Silverman

Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries

Remdesivir vial in bag

Pharmalot By Ed Silverman

Lawmakers urge congressional watchdog to probe U.S. government’s role in discovering remdesivir

Pharmalot By Ed Silverman

Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain

Pharma By Matthew Herper and Damian Garde

Pfizer and BioNTech pick Covid-19 vaccine and begin pivotal study

Cambridge: Biogen

Pharmalot By Ed Silverman

New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug

Opioid Lawyers

Pharmalot By Ed Silverman

Generic group fails again to block California law that bans pay-to-delay deals

Pharmalot By Ed Silverman

Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort

Pharmalot By Elizabeth Cooney

Pharmalittle: Moderna loses a key patent decision; China says its Covid-19 vaccine will be ready this year

medication overload

In the Lab By Elizabeth Cooney

‘Inactive’ drug ingredients are not always inactive, study finds